BMS Claims First Life-Sciences DGX SuperPOD Buy in AI Drug-Discovery Push

Bristol Myers Squibb says it is the first life-sciences firm to acquire Nvidia's DGX SuperPOD supercomputing system, signaling pharma's escalating bet on hyperscale AI for genomics and drug development.

ndtv-profit-business · 7/20/2026, 2:02:46 PM · Ask about this →